摘要
目的观察宁泌泰胶囊用于治疗伴有前列腺炎的精液不液化症的不育患者的临床疗效。方法选择62例伴有前列腺炎的精液不液化症患者,随机分为2组。其中治疗组31例,口服宁泌泰胶囊,每日3次,每次4粒;对照组31例,口服左氧氟沙星片,每日1次,每次1片,均治疗4周。以美国国立卫生研究院慢性前列腺炎症状积分指数(NIH-CPSI)为评价指标,通过计算机辅助精液分析系统,比较2组患者治疗前后的精液液化时间、精子活力和慢性前列腺炎NIH-CPSI评分的变化。结果治疗4周后,治疗组的精液液化时间、精子活力改善程度明显优于对照组(P<0.01)。治疗组的NIH-CPSI总分的改善程度较对照组明显(P<0.05)。结论宁泌泰胶囊治疗伴有前列腺炎的精液不液化症,可显著缩短精液液化时间、提高精子活力,并降低NIH-CPSI评分,故值得临床推广应用。
Objective To observe theclinical effect of Ningmitai capsule in the treatment of non-liquefaction of semen caused by chronic prostatitis. Methods 62 cases of patients with non-liquefaction of semen caused by chronic prostatitis were divided into two groups（ treatment group and control group） in a randomized controlled trial. The treatment group received oral Ningmitai capsule（4 capsules, tid）, and the control group received oral levofloxacin hydrochloric tablet（qd）. The duration of the trial was 4 weeks.The NIH-chronic prostatitis symptom index（NIH-CPSI）, the time of liquefaction and motility of sperm before and after the treat-ment were obtained. Results After 4 weeks of treatment, the time of liquefaction and motility of sperm of the treatment group was bet-ter than control group（ P〈0.01）, and the NIH-chronic prostatitis symptom index（ NIH-CPSI） of the treatment group was better than that of control group（P〈0.05）. Conclusion Ningmitai capsule has well therapeutic effect in treating non-liquefaction of semen,can obviously shorten liquefaction time, elevate motility of sperm and decrease NIH-CPSI score, so it is worthy of promotion and application.
出处
《中国中医药现代远程教育》
2016年第23期131-132,共2页
Chinese Medicine Modern Distance Education of China
关键词
宁泌泰胶囊
慢性前列腺炎
精液不液化
不育症
Ningmitai capsule
chronic prostatitis
non-liquefaction of semen
barrenness
